[ORGANIZATION]
NMPA
Featured in 2 tracked stories · first seen
Situations
Bayer Hyrnuo regulatory approvals for lung cancer
2 clusters · 4 sources · last updated
Latest: Bayer receives US FDA approval for lung cancer drug Hyrnuo
Bayer has secured regulatory approvals for its lung cancer drug, Hyrnuo (sevabertinib), in major international markets. In August 2026, Japan’s Ministry of Health, Labour and Welfare approved the therapy for patients w
CAR T-cell therapy market and research developments
3 clusters · 4 sources · last updated
Latest: CARsgen Therapeutics announces 2026 interim results
The global CAR T-cell therapy market is projected to experience significant growth through the end of the decade. Early projections estimated the market would reach approximately $13.56 billion by 2031, driven by rising